• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Intravenous sotalol for conversion of atrial flutter in infants.

作者信息

Aljohani Othman A, Perry James C, Williams Matthew R

机构信息

Division of Cardiology, Department of Pediatrics, Rady Children's Hospital, University of California, San Diego, California.

出版信息

HeartRhythm Case Rep. 2018 Jan 10;4(3):117-120. doi: 10.1016/j.hrcr.2018.01.002. eCollection 2018 Mar.

DOI:10.1016/j.hrcr.2018.01.002
PMID:29707488
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5918188/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c918/5918188/212abe116fde/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c918/5918188/adcb61207c7d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c918/5918188/212abe116fde/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c918/5918188/adcb61207c7d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c918/5918188/212abe116fde/gr2.jpg

相似文献

1
Intravenous sotalol for conversion of atrial flutter in infants.静脉注射索他洛尔用于婴儿房扑的转复
HeartRhythm Case Rep. 2018 Jan 10;4(3):117-120. doi: 10.1016/j.hrcr.2018.01.002. eCollection 2018 Mar.
2
Pharmacologic conversion and suppression of experimental canine atrial flutter: differing effects of d-sotalol, quinidine, and lidocaine and significance of changes in refractoriness and conduction.实验性犬心房扑动的药物转复与抑制：d-索他洛尔、奎尼丁和利多卡因的不同作用以及不应期和传导改变的意义
Circulation. 1986 Jul;74(1):197-204. doi: 10.1161/01.cir.74.1.197.
3
Efficacy of Intravenous Sotalol for Treatment of Incessant Tachyarrhythmias in Children.静脉注射索他洛尔治疗儿童持续性快速心律失常的疗效
Am J Cardiol. 2017 May 1;119(9):1366-1370. doi: 10.1016/j.amjcard.2017.01.034. Epub 2017 Feb 10.
4
Fetal atrial flutter: a case report and experience of sotalol treatment.胎儿房扑：一例病例报告及索他洛尔治疗经验
Taiwan J Obstet Gynecol. 2006 Mar;45(1):79-82. doi: 10.1016/S1028-4559(09)60199-6.
5
Intravenous sotalol for the termination of supraventricular tachycardia and atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled study. Sotalol Multicenter Study Group.静脉注射索他洛尔终止室上性心动过速、心房颤动及扑动：一项多中心、随机、双盲、安慰剂对照研究。索他洛尔多中心研究组
Am Heart J. 1995 Apr;129(4):739-48. doi: 10.1016/0002-8703(95)90324-0.
6
Maintenance of sinus rhythm with oral d,l-sotalol therapy in patients with symptomatic atrial fibrillation and/or atrial flutter. d,l-Sotalol Atrial Fibrillation/Flutter Study Group.口服d，l-索他洛尔治疗有症状心房颤动和/或心房扑动患者时窦性心律的维持。d，l-索他洛尔心房颤动/心房扑动研究组
Am J Cardiol. 1999 Aug 1;84(3):270-7. doi: 10.1016/s0002-9149(99)00275-1.
7
[The effectiveness and safety of d,l-sotalol in the ambulatory treatment of atrial fibrillation and flutter].[盐酸索他洛尔在门诊治疗心房颤动和心房扑动中的有效性和安全性]
Arch Inst Cardiol Mex. 1998 Nov-Dec;68(6):482-91.
8
Arrhythmias in the intensive care patient.重症监护患者的心律失常
Curr Opin Crit Care. 2003 Oct;9(5):345-55. doi: 10.1097/00075198-200310000-00003.
9
Characterization of low right atrial isthmus as the slow conduction zone and pharmacological target in typical atrial flutter.将右心房峡部确定为典型心房扑动的缓慢传导区和药理学靶点
Circulation. 1997 Oct 21;96(8):2601-11. doi: 10.1161/01.cir.96.8.2601.
10
Efficacy, safety, and tolerance of d-sotalol in patients with refractory supraventricular tachyarrhythmias.d-索他洛尔治疗难治性室上性快速心律失常患者的疗效、安全性及耐受性。
Am Heart J. 1989 Mar;117(3):562-8. doi: 10.1016/0002-8703(89)90729-1.

引用本文的文献

1
IV Sotalol Use in Pediatric and Congenital Heart Patients: A Multicenter Registry Study.静脉注射索他洛尔在儿科和先天性心脏病患者中的应用：一项多中心注册研究。
J Am Heart Assoc. 2022 May 3;11(9):e024375. doi: 10.1161/JAHA.121.024375. Epub 2022 May 2.
2
Intravenous Sotalol for the Treatment of Ventricular Dysrhythmias in an Infant on Extracorporeal Membrane Oxygenation.静脉注射索他洛尔治疗接受体外膜肺氧合的婴儿室性心律失常
Pediatr Cardiol. 2020 Feb;41(2):418-422. doi: 10.1007/s00246-019-02225-w. Epub 2019 Oct 29.

本文引用的文献

1
Pediatric Dosing of Intravenous Sotalol Based on Body Surface Area in Patients with Arrhythmia.基于体表面积的心律失常患儿静脉注射索他洛尔的剂量
Pediatr Cardiol. 2017 Oct;38(7):1450-1455. doi: 10.1007/s00246-017-1683-9. Epub 2017 Jul 28.
2
Use of intravenous sotalol in newborns with supraventricular tachycardia.静脉注射索他洛尔在新生儿室上性心动过速中的应用。
HeartRhythm Case Rep. 2017 May 10;3(7):332-335. doi: 10.1016/j.hrcr.2017.03.010. eCollection 2017 Jul.
3
Efficacy of Intravenous Sotalol for Treatment of Incessant Tachyarrhythmias in Children.
静脉注射索他洛尔治疗儿童持续性快速心律失常的疗效
Am J Cardiol. 2017 May 1;119(9):1366-1370. doi: 10.1016/j.amjcard.2017.01.034. Epub 2017 Feb 10.
4
High-dose sotalol is safe and effective in neonates and infants with refractory supraventricular tachyarrhythmias.大剂量索他洛尔对患有难治性室上性心律失常的新生儿和婴儿是安全有效的。
Pediatr Cardiol. 2011 Oct;32(7):896-903. doi: 10.1007/s00246-011-0010-0. Epub 2011 May 8.
5
Atrial tachycardias in young adults and adolescents with congenital heart disease: conversion using single dose oral sotalol.先天性心脏病青年及青少年的房性心动过速：采用单剂量口服索他洛尔进行转复
Int J Cardiol. 2009 Aug 21;136(3):253-7. doi: 10.1016/j.ijcard.2008.04.060. Epub 2008 Jul 23.
6
Neonatal intractable atrial flutter successfully treated with intravenous flecainide.静脉注射氟卡尼成功治疗新生儿顽固性心房扑动。
Pediatr Cardiol. 2004 Mar-Apr;25(2):154-6. doi: 10.1007/s00246-003-0226-8. Epub 2003 Dec 23.
7
Neonatal atrial flutter: significant early morbidity and excellent long-term prognosis.新生儿心房扑动：早期发病率高，但长期预后良好。
Am Heart J. 1997 Mar;133(3):302-6. doi: 10.1016/s0002-8703(97)70224-2.
8
New antiarrhythmic drug in pediatric use: sotalol.
Pediatr Cardiol. 1997 Jan-Feb;18(1):28-34. doi: 10.1007/s002469900104.
9
Atrial tachycardia in infants and children: electrocardiographic classification and its significance.婴幼儿室上性心动过速：心电图分类及其意义。
Pediatr Cardiol. 1993 Oct;14(4):199-203. doi: 10.1007/BF00795370.
10
Amiodarone therapy of intractable atrial flutter in a premature hydropic neonate.胺碘酮治疗早产水肿新生儿顽固性心房扑动。
Pediatr Cardiol. 1992 Oct;13(4):227-9. doi: 10.1007/BF00838781.